By: Spencer Sherman, Pharm.D., Clinical Pharmacist, Enlyte Pharmacy Solutions On December 19, 2023, the U.S. Food and Drug Administration (FDA) approved the first test (AvertD) that uses DNA in assessing whether certain individuals may have an elevated […]
Author: Spencer Sherman, Pharm.D., Clinical Pharmacist, Enlyte Opioids continue to represent a decreasing portion of overall workers’ compensation prescriptions, with favorable trends being seen in markers such as dose and duration of use. Despite declines, […]
Sarasota, FL (WorkersCompensation.com) -- OxyContin, developed by Purdue Pharma, emerged as a powerful opioid painkiller with a profound influence on the workers' compensation system. Initially seen as a revolutionary approach to pain management, this drug […]
Sarasota, FL (WorkersCompensation.com) -- The story of Purdue Pharma is deeply intertwined with the workers' compensation community, where its flagship product, OxyContin, has had far-reaching consequences. OxyContin, introduced in the late 1990s, promised revolutionary pain […]
Charleston, WV (WorkersCompensation.com) -- Whether medication is necessary is a medical decision, but for workers' compensation purposes, it is also a legal question, often with a court having the final say. For example, in Becca […]
Waynesville, MO (WorkersCompensation.com) – Employers’ policies often call for discipline when an employee violates an internal drug policy. It can complicate matters, however, when an employee files a workers’ compensation claim around the same time. […]
Minneapolis, MN (WorkersCompensation.com) -- In Minnesota, treatment parameters are set up to keep costs low when an injured worker is under medical care. But as was the case in McKeever v. Cub Foods, No. WC22-6499 […]
Washington, DC (WorkersCompensation.com) – Last week, the U.S. Supreme Court blocked Purdue Pharma from going forward with its bankruptcy proceedings, a move President Joe Biden said would offer the Sackler family protections from opioid-related civil […]